Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "chitosan"

3 News Found

Novel smart wound dressing from NIT Rourkela enables pain-free dressing changes
Medical Device | June 30, 2026

Novel smart wound dressing from NIT Rourkela enables pain-free dressing changes

The cost-effective dressing combines chitosan-coated cotton gauze with a curcumin-loaded nanofibrous layer to minimise tissue damage, prevent infections, and accelerate wound healing while reducing discomfort during dressing changes

MedVital raises Rs. 18 crore to scale medical technologies in advanced wound care
Medical Device | May 06, 2026

MedVital raises Rs. 18 crore to scale medical technologies in advanced wound care

The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering
R&D | April 20, 2026

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Shailesh Pednekar appointed COO – International Business at Bharat Serums and Vaccines

Merck consolidates India tech operations under new Bengaluru GCC

ZeeLab Pharmacy launches iOS app to expand affordable digital healthcare access

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International

Packaging